The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine marstacimab (Hympavzi) to prevent or reduce bleeding in patients 12 years of age and older weighing at least 35 ...

Is depression genetic? To a degree, yes. In this article, learn how genetics, family history, and other risk factors ...

DelveInsight's "HEMLIBRA Market Size, Forecast, and Market Insight Report" highlights the details around HEMLIBRA, a ...

Many people in Kenya may be living with an undiagnosed rare bleeding disorder known as hemophilia, which may put them at risk in emergency cases. People with hemophilia have a defect in a gene that ...

Aug. 29, 2024 — For decades, scientists have dreamt of a future where genetic diseases, such as the blood clotting disorder hemophilia, could be a thing of the past. Gene therapy, the idea of ...

The provision of medical care to hemophiliacs is in the hands of health professionals at the Institute of Hematology and ...

Genetic mutation causing hemophilia in European monarchies, underdiagnosed in India, requires improved treatment and ...

Hemophilia is a genetic condition where the body doesn't produce enough of the clotting factors needed to stop bleeding. Know ...

This World Hemophilia Day, global focus shifts to the often-overlooked struggles of women with haemophilia, calling for ...

This World Hemophilia Day, let us break the silence surrounding bleeding disorders in both women and men and advocate for ...

If blood clotting is affected for a longer period of time it can cost your life! Read this article to understand more about ...

Hemophilia is a rare genetic bleeding disorder caused by a deficiency in certain clotting factors, which prevents blood from ...